A fraction containing kaempferol-3,4'-dimethylether from Larrea divaricata Cav. induces macrophage activation on mice infected with Candida albicans.

Larrea divaricata Cav. is a plant growing in South America. Both the infusion and a derived fraction (F1) of L. divaricata have proved to have immunomodulatory properties. Moreover, F1 can activate macrophages obtained from mice infected with Candida albicans. In this work, F1 was administrated to infected animals, and the state and type of activation of resident macrophages were studied. Results showed that F1 was able to activate macrophages obtained from infected mice by both classical and alternative pathways, probably by inducing a translocation of nuclear factor kappa-B. F1 increases not only the lysosomal activity of macrophages but also the production of phagosomal superoxide anion as a consequence of the activation of the Nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase) complex. F1 induced an increase in the macrophage capacity to kill the fungus, which was reflected in a decrease in the levels of colonization of organs. A main flavonoid, kaempferol-3,4'-dimethylether, was identified in F1 by HPLC. This compound increased in vitro production of nitric oxide in heat-killed C. albicans-stimulated macrophages. The flavonoid could thus be considered one of the responsible molecules mediating the overall effects of F1 on the immune system in infected animals.

In vivo immunomodulatory effects of aqueous extracts of Larrea divaricata Cav.

Several medicinal plants are considered immunomodulatory as they display a variety of anti-inflammatory, antimicrobial and antitumoral effects. Larrea divaricata Cav. (jarilla) (Zygophyllaceae) is a plant widely used in popular medicine to treat tumors, infections, and inflammatory diseases. So far, the immunostimulating activities of Larrea divaricata have not been studied in vivo. In this work, we used healthy mice to assess the immunomodulatory potential of aqueous extracts of Larrea divaricata Cav. We found that Decoction (D) and Infusion (I) from Larrea divaricata Cav showed any acute hepatotoxic activity. Only D at 0.5 mg/kg increased the carrageenan-induced inflammation. Macrophages harvested from treated mice showed no signs of apoptosis. These cells showed a significant increase in NO and TNF-alpha release and exhibited the strongest expression of iNOS. Decoction also increased the phagocytosis of zymosan and the binding of LPS-FITC. The expression of CD14, TLR4 and CR3 was lower in macrophages of mice treated than in controls. Thus, Larrea divaricata was able to prime Mphi in vivo and to induce full activation in vitro. Our finding contribute to characterize the biological activity of Larrea divaricata and to understand the ability of these extracts to enhance immune responses.

Early effects triggered by Larrea divaricata Cav. on murine macrophages at apoptotic concentrations.

Decoction and infusion of Larrea divaricata were tested at apoptotic concentrations (1 and 4 mg/ml) on peritoneal murine macrophages. Consistent changes were observed after incubation with 4 mg/ml decoction. Phagocytosis of zymosan, lysosomal enzyme activity, nitric oxide production, TNF-alpha release, and expression of CD14, TLR4, and CR3 increased significantly. Decoction at 1 and 4 mg/ml increased the binding of LPS-FITC. Apoptosis triggered by L. divaricata decoction is consequence of cell activation. The effects are independent of nordihydroguaiaretic acid. This "activation and death" could be the mechanism of L. divaricata to exert the antituberculosis effect known in folk medicine.

Activation and apoptosis of mouse peritoneal macrophages by extracts of Larrea divaricata Cav. (jarilla).

Two aqueous extracts, decoction and infusion from Larrea divaricata Cav. (Zygophyllaceae) were investigated for immunomodulating activity on peritoneal macrophages (MPhi). Both extracts reduced significantly the cell viability assessed with the MTT assay at 1 and 4 mg/ml (decoction) and 0.8-4 mg/ml (infusion). Apoptotic morphology showed that at 1 and 4 mg/ml both infusion and decoction triggered an increment of the apoptosis. Pretreatment of MPhi with decoction increased significantly the phagocytosis of zymosan and Candida albicans. The production of NO was estimated as nitrite using the Griess reagent. A slight but significant increase in NO release was observed after the incubation of both extracts (0.2 mg/ml) with LPS during 48 h. As shown in western blot data MPhi cultured with infusion and LPS exhibited the stronger expression of iNOS compared with untreated cells. Both extracts (0.2 mg/ml) increased the binding of LPS-FITC to cells compared with untreated ones. The addition of Staphylococcus aureus blocked completely the binding of LPS-FITC to cells. L. divaricata stimulated the MPhi activation at 0.2 mg/ml whereas it showed a clear pro-apoptotic activity at higher concentrations. The dual effects of L. divaricata are relevant considering the use of this plant to activate the immune system.